← SynDRA
ABT-702
SynDRA canonical compound SYN1955704 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ADK |
| Mechanism of action | adenosine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- adenosine kinase inhibitor
Cross-references
Synonyms
- Abt 702
- ABT702
- CHEMBL66089
- UNII-2P206WS5B3
- 2P206WS5B3
- 5-(3-bromophenyl)-7-[6-(morpholin-4-yl)pyridin-3-yl]pyrido[2,3-d]pyrimidin-4-amine
- 5-(3-Bromo-phenyl)-7-(6-morpholin-4-yl-pyridin-3-yl)-pyrido[2,3-d]pyrimidin-4-ylamine
- AC1L1CN5
- SCHEMBL1914142
- GTPL5131
- CTK5I8409
- MolPort-035-936-400
- CHEBI:104129
- ZINC21288919
- BDBM50094703
- AKOS030589605
- SMP2_000264
- NCGC00092381-03
- NCGC00092381-02
- LS-134028
- BRD-K36021395-300-01-6
- 5-(3-bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine
Look up ABT-702 in the interactive SynDRA portal →